Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/232195 
Year of Publication: 
2017
Series/Report no.: 
Research Paper No. 77
Publisher: 
South Centre, Geneva
Abstract: 
"Viral hepatitis is an international public health challenge, comparable to other major communicable diseases, including HIV, tuberculosis and malaria. Despite the significant burden it places on communities across all global regions, hepatitis has been largely ignored as a health and development priority until recently". - WHO, Global Health Sector strategy on viral Hepatitis 2016-2021: Towards ending viral hepatitis. This document will address five items: 1) General context and background on the debate over access to medicines. 2) The problem of the Hepatitis C virus (HCV): Figures and data. 3) Access to new direct-acting antiviral (DAA) treatments for Hepatitis C. 4) How to overcome barriers to access: using the flexibilities of the TRIPS Agreement. 5) Some examples of countries that have launched the new HCV treatment and Conclusions.
Document Type: 
Research Report
Appears in Collections:

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.